Advanced Cancer Diagnostics Market Worth $3,924.01 Million by 2018 – New Report by MarketsandMarkets
PR Web |
(PRWEB)
The "Tissue Diagnostics Market by Technology (Immunohistochemistry, in Situ Hybridization, Digital pathology & Workflow, Special Staining), Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non Small Cell Lung Cancer and Others), Product (Instruments and Consumables), End-Users (Hospitals, Pharmaceutical companies, Research Laboratories, Contract Research Organizations and Others) & by Region (The
The global tissue diagnostics market is expected to grow at a CAGR of close to 6.97% between 2013 and 2018, to reach
For Further Inquiries: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=1063949
According to GLOBOCAN, about 14.1 million new cancer cases and 8.2 million cancer-related deaths were recorded globally in 2012. Based on GLOBOCAN's statistics, the
The tissue diagnostics market includes a number of highly specialized diagnostic tests based on immunohistochemistry, in situ hybridization, and special staining. This market includes instruments and consumables for each of these diagnostic procedures. Furthermore, there are separate and highly specific test kits which are based on multiple markers for different types of cancers. These test kits depend on the large number and patterns of multiple cell surface markers to identify cancer cells and differentiate between different types of cancer cells. As such, these test kits allow for identification of not just the type, but also the stage and prognosis of multiple types of cancers. Furthermore, tissue diagnostic-based products are also being used as companion diagnostics for identifying treatment-responsive clinical trial candidates for investigational drug products. With a large number of products present in the tissue diagnostics market, it becomes important to identify the current market size and future market potential for each of them. This information will enable market players make well informed decisions about growth strategies in this highly competitive and rapidly evolving market.
Request for customization of report @ http://www.marketsandmarkets.com/requestCustomization.asp?id=1063949.
Organizational diagnostics market, including immunohistochemistry and in situ hybridization, special staining based on a number of professional diagnostic tests. This market includes tools and supplies in each diagnostic method. In addition, the number of marks as there is different types of cancer with high specificity, respectively, based on a detection kit. Testing of these groups will depend on a large number of surface markers used to identify a pattern and some tumor cells and various types of differentiated cells in the tumor cells. Therefore, these test kits allow the identification of not only the type, but there are also staging and prognosis of many types of cancer. Moreover, according to the organization's diagnostic products are also being used as a diagnostic to identify response processing associated with the study drug candidates in clinical trials. Due to a large number of diagnostic tissue products on the market becomes very important to determine each of them market the current market size and growth potential. This information will allow market participants to decide in this highly competitive and rapidly changing market of the future strategy of fully informed.
Based on geography, the global tissue diagnostics market is segmented into the
The major players in the tissue diagnostics market are
Browse Related Reports:
Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Service, Software) - Global Forecasts to 2018
http://www.marketsandmarkets.com/Market-Reports/molecular-diagnostic-market-833.html
Point-Of-Care Diagnostics/Testing Market by Products (Glucose Monitoring & Infectious Diseases Testing Kits, Cardiac & Tumor Markers), by End Users (Self & Professional Monitoring), Over the Counter & Prescription Based - Global Forecast to 2018
http://www.marketsandmarkets.com/Market-Reports/point-of-care-diagnostic-market-106829185.html
About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.
We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact:
17304,
Suite 800,
Tel: +1-888-600-6441
Email: sales(at)marketsandmarkets(dot)com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/medical-devices.
Connect with us on
Read the full story at http://www.prweb.com/releases/advanced-cancer/diagnostics-market/prweb12036353.htm
Copyright: | (c) 2014 PRWEB.COM Newswire |
Wordcount: | 972 |
Neuberger Berman Appoints Former KKR Executive Clifford Chiu As Senior Adviser For Asia
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News